202 related articles for article (PubMed ID: 8604046)
1. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.
Flores G; Barbeau D; Quirion R; Srivastava LK
J Neurosci; 1996 Mar; 16(6):2020-6. PubMed ID: 8604046
[TBL] [Abstract][Full Text] [Related]
2. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.
Flores G; Wood GK; Liang JJ; Quirion R; Srivastava LK
J Neurosci; 1996 Nov; 16(22):7366-75. PubMed ID: 8929443
[TBL] [Abstract][Full Text] [Related]
3. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Hillefors M; von Euler G
Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
[TBL] [Abstract][Full Text] [Related]
5. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.
Stanwood GD; McElligot S; Lu L; McGonigle P
Neurosci Lett; 1997 Feb; 223(1):13-6. PubMed ID: 9058411
[TBL] [Abstract][Full Text] [Related]
9. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
Gonzalez AM; Sibley DR
Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
[TBL] [Abstract][Full Text] [Related]
10. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Baldessarini RJ
Neuroscience; 1998 Nov; 87(1):1-4. PubMed ID: 9722137
[TBL] [Abstract][Full Text] [Related]
11. Neonatal ventral hippocampus lesion alters the dopamine content in the limbic regions in postpubertal rats.
Alquicer G; Silva-Gómez AB; Peralta F; Flores G
Int J Dev Neurosci; 2004 Apr; 22(2):103-11. PubMed ID: 15036385
[TBL] [Abstract][Full Text] [Related]
12. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats.
Morales-Medina JC; Mejorada A; Romero-Curiel A; Aguilar-Alonso P; León-Chávez BA; Gamboa C; Quirion R; Flores G
Neuropharmacology; 2008 Dec; 55(8):1313-20. PubMed ID: 18790702
[TBL] [Abstract][Full Text] [Related]
13. Post-pubertal adrenergic changes in rats with neonatal lesions of the ventral hippocampus.
Bhardwaj SK; Quirion R; Srivastava LK
Neuropharmacology; 2004 Jan; 46(1):85-94. PubMed ID: 14654100
[TBL] [Abstract][Full Text] [Related]
14. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
Thomas WS; Neal-Beliveau BS; Joyce JN
Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
[TBL] [Abstract][Full Text] [Related]
15. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study.
Cagnotto A; Parotti L; Mennini T
Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions.
Hori T; Subramaniam S; Srivastava LK; Quirion R
Neuropharmacology; 2000 Sep; 39(12):2478-91. PubMed ID: 10974332
[TBL] [Abstract][Full Text] [Related]
17. Behavioral changes in rats with early ventral hippocampal damage vary with age at damage.
Wood GK; Lipska BK; Weinberger DR
Brain Res Dev Brain Res; 1997 Jul; 101(1-2):17-25. PubMed ID: 9263576
[TBL] [Abstract][Full Text] [Related]
18. Effect of repeated treatment with milnacipran on the central dopaminergic system.
Rogóz Z; Margas W; Dlaboga D; Góralska M; Dziedzicka-Wasylewska M; Maj J
Pol J Pharmacol; 2000; 52(2):83-92. PubMed ID: 10949109
[TBL] [Abstract][Full Text] [Related]
19. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
Khroyan TV; Fuchs RA; Beck AM; Groff RS; Neisewander JL
Psychopharmacology (Berl); 1999 Mar; 142(4):383-92. PubMed ID: 10229063
[TBL] [Abstract][Full Text] [Related]
20. Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.
Bardgett ME; Henry JD
Neuroscience; 1999; 94(1):59-70. PubMed ID: 10613497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
